Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 347,700 shares, a drop of 12.0% from the January 15th total of 395,200 shares. Approximately 2.2% of the company’s stock are sold short. Based on an average daily volume of 80,700 shares, the days-to-cover ratio is presently 4.3 days.
Insider Buying and Selling at Addus HomeCare
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 377 shares of the firm’s stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $103.54, for a total value of $39,034.58. Following the completion of the transaction, the executive vice president now directly owns 6,387 shares in the company, valued at $661,309.98. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, EVP Sean Gaffney sold 6,626 shares of the firm’s stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $107.07, for a total value of $709,445.82. Following the completion of the sale, the executive vice president now directly owns 12,826 shares of the company’s stock, valued at $1,373,279.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 377 shares of the firm’s stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $103.54, for a total value of $39,034.58. Following the completion of the sale, the executive vice president now directly owns 6,387 shares of the company’s stock, valued at $661,309.98. The disclosure for this sale can be found here. Insiders sold a total of 15,555 shares of company stock worth $1,651,374 over the last ninety days. 4.50% of the stock is currently owned by corporate insiders.
Institutional Trading of Addus HomeCare
Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in Addus HomeCare by 1.4% in the 1st quarter. BlackRock Inc. now owns 2,664,889 shares of the company’s stock valued at $248,608,000 after acquiring an additional 37,830 shares in the last quarter. Vanguard Group Inc. raised its holdings in Addus HomeCare by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 1,115,872 shares of the company’s stock valued at $106,276,000 after acquiring an additional 12,363 shares in the last quarter. Eaton Vance Management raised its holdings in Addus HomeCare by 1.6% in the 3rd quarter. Eaton Vance Management now owns 757,813 shares of the company’s stock valued at $72,175,000 after acquiring an additional 12,046 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Addus HomeCare by 17.7% in the 2nd quarter. Principal Financial Group Inc. now owns 605,038 shares of the company’s stock valued at $50,387,000 after acquiring an additional 90,927 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Addus HomeCare by 2.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 604,200 shares of the company’s stock valued at $60,112,000 after acquiring an additional 13,220 shares in the last quarter. 97.42% of the stock is owned by institutional investors and hedge funds.
Addus HomeCare Stock Performance
NASDAQ:ADUS opened at $104.90 on Wednesday. The stock has a market cap of $1.69 billion, a P/E ratio of 38.15, a PEG ratio of 2.70 and a beta of 0.83. The stock has a 50 day simple moving average of $104.30 and a 200 day simple moving average of $100.94. The company has a current ratio of 1.87, a quick ratio of 1.87 and a debt-to-equity ratio of 0.27. Addus HomeCare has a 1-year low of $68.57 and a 1-year high of $112.89.
Analyst Upgrades and Downgrades
A number of research firms have recently issued reports on ADUS. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 14th. Royal Bank of Canada raised their price objective on Addus HomeCare from $110.00 to $121.00 and gave the company an “outperform” rating in a research report on Wednesday, November 2nd. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $112.60.
About Addus HomeCare
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled.